资源中心

Jaranol: a compound with therapeutic activity against pathological cardiac remodelling via multi-target inhibition of the Snai3/TLR2 and NF-κB signaling pathways

发布时间：

1970-01-01

Zhang Y, Li N, Chu S, Fu H, Yang X, Xia H, Xiao Y, Xiao Z, Liu J, Dong Y, Liu T. Jaranol: a compound with therapeutic activity against pathological cardiac remodelling via multi-target inhibition of the Snai3/TLR2 and NF-κB signaling pathways. Front Pharmacol. 2026 Jan 2;16:1723889. doi: 10.3389/fphar.2025.1723889.

上一个

Magnoflorine attenuates Ang II-induced cardiac remodeling via promoting AMPK-regulated autophagy

无

下一个

上一个：

Magnoflorine attenuates Ang II-induced cardiac remodeling via promoting AMPK-regulated autophagy

下一个：

无

活动中心

α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure

1970-01-01

BAF155 promotes cardiac hypertrophy and fibrosis through inhibition of WWP2-mediated PARP1 ubiquitination

1970-01-01

Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction

1970-01-01

Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo

1970-01-01

Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles

1970-01-01

Construction of tissue-engineered vascular grafts with enhanced patency by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels

1970-01-01

分享到

返回列表